ConductScience.org, home

Paper39259459

In Vitro and in vivo characterization of nasal pH-Responsive in-situ hydrogel of Candesartan-loaded invasomes as a potential stroke treatment.

El-Housiny S and 6 others. Drug Deliv Transl Res, 2025. Cited by 2 papers, by iCite.

Cite this record

ConductScience Library. In Vitro and in vivo characterization of nasal pH-Responsive in-situ hydrogel of Candesartan-loaded invasomes as a potential stroke treatment. Papers, record 39259459. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39259459

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
In Vitro and in vivo characterization of nasal pH-Responsive in-situ hydrogel of Candesartan-loaded invasomes as a potential stroke treatment.
PubMed
Journal
Drug Deliv Transl Res
PubMed
Year
2025
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
2
iCite
Revised in PubMed
2026-11-02
PubMed

Authors7

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1El-Housiny SShaimaa
2Fouad AGAmr Gamalhttps://orcid.org/0000-0002-0082-4160
3El-Bakry RRana
4Zaki RMRanda Mohammed
5Afzal OObaid
6El-Ela FIAFatma I Abo
7Ghalwash MMMaha M

Source PubMed

Download CSV of authors

Topics14

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
BenzimidazolesMajor topic
HydrogelsMajor topic
TetrazolesMajor topic
StrokeMajor topic
Animals
Biphenyl Compounds
Hydrogen-Ion Concentration
Male
Administration, Intranasal
Rats
Drug Liberation
Rats, Sprague-Dawley
Biological Availability
Nasal Mucosa

Source PubMed

Download CSV of topics

References73

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
136985306Synthesis of Carvacrol-Loaded Invasomes Nanoparticles Improved Acaricide Efficacy, Cuticle Invasion and Inhibition of Acetylcholinestrase against Hard Ticks.Microorganisms2023https://conductscience.org/library/papers/36985306PubMed
233209023Low-Frequency versus High-Frequency Ultrasound-Mediated Transdermal Delivery of Agomelatine-Loaded Invasomes: Development, Optimization and in-vivo Pharmacokinetic Assessment.Int J Nanomedicine2020https://conductscience.org/library/papers/33209023PubMed
319454737Use of blood pressure lowering drugs in the prevention of cardiovascular disease: meta-analysis of 147 randomised trials in the context of expectations from prospective epidemiological studies.BMJ2009https://conductscience.org/library/papers/19454737PubMed
434304580Comparative First-Line Effectiveness and Safety of ACE (Angiotensin-Converting Enzyme) Inhibitors and Angiotensin Receptor Blockers: A Multinational Cohort Study.Hypertension2021https://conductscience.org/library/papers/34304580PubMed
536117589Candesartan Reduces Neuronal Apoptosis Caused by Ischemic Stroke via Regulating the FFAR1/ITGA4 Pathway.Mediators Inflamm2022https://conductscience.org/library/papers/36117589PubMed
619788905The safety of chitosan as a pharmaceutical excipient.Regul Toxicol Pharmacol2010https://conductscience.org/library/papers/19788905PubMed
724865287Candesartan cilexetil loaded solid lipid nanoparticles for oral delivery: characterization, pharmacokinetic and pharmacodynamic evaluation.Drug Deliv2016https://conductscience.org/library/papers/24865287PubMed
831900659Treatment of Basal Cell Carcinoma Via Binary Ethosomes of Vismodegib: In Vitro and In Vivo Studies.AAPS PharmSciTech2020https://conductscience.org/library/papers/31900659PubMed
934683853Improving the Antitumor Activity and Bioavailability of Sonidegib for the Treatment of Skin Cancer.Pharmaceutics2021https://conductscience.org/library/papers/34683853PubMed
1028154100Stroke Caused by Atherosclerosis of the Major Intracranial Arteries.Circ Res2017https://conductscience.org/library/papers/28154100PubMed
1122297749Ethosomes, binary ethosomes and transfersomes of terbinafine hydrochloride: a comparative study.Arch Pharm Res2012https://conductscience.org/library/papers/22297749PubMed
1223444308Association of hypertension with stroke recurrence depends on ischemic stroke subtype.Stroke2013https://conductscience.org/library/papers/23444308PubMed
1334506923Design of long acting invasomal nanovesicles for improved transdermal permeation and bioavailability of asenapine maleate for the chronic treatment of schizophrenia.Int J Pharm2021https://conductscience.org/library/papers/34506923PubMed
1431360232Hypertension and Stroke: Update on Treatment.Eur Cardiol2019https://conductscience.org/library/papers/31360232PubMed
1530726749Chitosan coated human serum albumin nanoparticles: A promising strategy for nose-to-brain drug delivery.Int J Biol Macromol2019https://conductscience.org/library/papers/30726749PubMed
1631491483Development of an optimized avanafil-loaded invasomal transdermal film: Ex vivo skin permeation and in vivo evaluation.Int J Pharm2019https://conductscience.org/library/papers/31491483PubMed
1719265050Candesartan augments ischemia-induced proangiogenic state and results in sustained improvement after stroke.Stroke2009https://conductscience.org/library/papers/19265050PubMed
1821269482Comparison of dietary control and atorvastatin on high fat diet induced hepatic steatosis and hyperlipidemia in rats.Lipids Health Dis2011https://conductscience.org/library/papers/21269482PubMed
1931323280Liposomes for drug delivery in stroke.Brain Res Bull2019https://conductscience.org/library/papers/31323280PubMed
2027418824Charge effect of a liposomal delivery system encapsulating simvastatin to treat experimental ischemic stroke in rats.Int J Nanomedicine2016https://conductscience.org/library/papers/27418824PubMed

See all 73 referencesDownload CSV of references

Cited by2

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 2 citations.

PMIDTitleJournalYearIn PapersSource
42458150Nose-to-brain delivery of candesartan-loaded nanoemulsion: brain biodistribution and neurobehavioral outcomes in controlled cortical impact-induced traumatic brain injury.Inflammopharmacology2026https://conductscience.org/library/papers/42458150PubMed
42414694Control of cardiotoxicity via nasal in-situ pH-sensitive transbilosomal formulation of candesartan.Naunyn Schmiedebergs Arch Pharmacol2026https://conductscience.org/library/papers/42414694PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/39259459

GET https://conductscience.org/api/papers/v1/39259459/references?page=2